Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis.
about
ICOS Co-Stimulation: Friend or Foe?Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection.Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice.B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responsesRegulation of granulomatous inflammation in experimental models of schistosomiasisThe immunobiology of Th1 polarization in high-pathology schistosomiasis.Priming of the immune response by schistosome eggs.The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infectionAlternatively activated macrophages in helminth infections.Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.Infection-stimulated anemia results primarily from interferon gamma-dependent, signal transducer and activator of transcription 1-independent red cell loss.Disruption of interleukin-27 signaling results in impaired gamma interferon production but does not significantly affect immunopathology in murine schistosome infectionRole for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.Expression of IFN-γ, IL-4, and IL-17 in cutaneous schistosomal granuloma.Peritoneal macrophages suppress T-cell activation by amino acid catabolism.
P2860
Q28072305-EE707B38-9C35-4A26-AB0B-3C7604B0E6B2Q33896026-C3F6CD05-14B8-49F1-8341-8C440417875BQ34973340-4BF110AE-40AC-40B4-A713-6139F40928A6Q35607509-F2983191-71E6-42C9-8B92-5FF690A15F33Q35612556-A3C3E8D2-BB53-484E-AD98-E08C9EA1689EQ35884229-1D9C7506-18D2-44B5-A85F-AC2811619129Q36247356-4284E8FD-7D0E-4C08-B9B4-B5F531C73BE5Q36443069-329F637E-3056-4F13-A29E-2E49BCD862B2Q36736390-75F1C909-04F3-4C1D-A94F-A7FD1C82DC79Q36911886-6606429B-C9BA-4DBE-B52E-76C1BA872195Q36949600-62AD6890-EA53-4B0C-98E4-BF4B66303666Q40108993-58C5B3D5-1C83-4878-9145-C69D2762B651Q40254628-5CCD42FF-7398-4643-B504-460FF6FAE49DQ41963983-1A696667-29D6-4419-8841-2622D12A9989Q43113194-5B2566B2-B068-4B41-A621-7F9028B58661Q46201856-C69767D9-0AFC-40AF-AA06-8980084341A3Q46942451-FFD6DBFF-7176-42AE-A0B9-B51EEBF46795
P2860
Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@ast
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@en
type
label
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@ast
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@en
prefLabel
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@ast
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@en
P2093
P2860
P1476
Disruption of the ICOS-B7RP-1 ...... lls in murine schistosomiasis.
@en
P2093
Engin Ozkaynak
James B Rottman
Laura I Rutitzky
Miguel J Stadecker
P2860
P304
P356
10.1128/IAI.71.7.4040-4044.2003
P407
P577
2003-07-01T00:00:00Z